Australia markets closed

Anatara Lifesciences Ltd (ANR.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0460+0.0030 (+6.98%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 7.22M
Enterprise value 5.93M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.31
Price/book (mrq)5.69
Enterprise value/revenue 5.61
Enterprise value/EBITDA -2.95

Trading information

Stock price history

Beta (5Y monthly) 0.74
52-week change 376.17%
S&P500 52-week change 325.01%
52-week high 30.0488
52-week low 30.0207
50-day moving average 30.0339
200-day moving average 30.0292

Share statistics

Avg vol (3-month) 3163.36k
Avg vol (10-day) 3263.58k
Shares outstanding 5167.89M
Implied shares outstanding 6167.89M
Float 8105.76M
% held by insiders 136.11%
% held by institutions 17.58%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-250.38%

Management effectiveness

Return on assets (ttm)-65.37%
Return on equity (ttm)-117.14%

Income statement

Revenue (ttm)-123.18k
Revenue per share (ttm)-0.00
Quarterly revenue growth (yoy)-31.10%
Gross profit (ttm)N/A
EBITDA -1.76M
Net income avi to common (ttm)-1.75M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.08M
Total cash per share (mrq)0.01
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)8.90
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-1.54M
Levered free cash flow (ttm)-948.77k